Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virios Therapeutics Inc
(NQ:
VIRI
)
0.1800
-0.0050 (-2.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virios Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
A Preview Of Virios Therapeutics's Earnings
March 13, 2023
Via
Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 07, 2022
Wednesday saw 219 companies set new 52-week lows.
Via
Benzinga
Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase
November 29, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022
November 03, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 26, 2022
On Wednesday, 53 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
During Tuesday's session, 78 companies made new 52-week lows.
Via
Benzinga
How Is The Market Feeling About Virios Therapeutics?
October 05, 2022
Virios Therapeutics's (NASDAQ:VIRI) short percent of float has fallen 53.09% since its last report. The company recently reported that it has 63 thousand shares sold short, which is 0.38% of all...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 10, 2022
During Monday's trading, 528 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 27, 2022
On Tuesday, 456 stocks hit new 52-week lows.
Via
Benzinga
Virios Therapeutics, Inc. Announces Closing of Public Offering
September 22, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 22, 2022
It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.
Via
InvestorPlace
Short Volatility Alert: Virios Therapeutics, Inc.
September 21, 2022
On Tuesday, shares of Virios Therapeutics, Inc. (NASDAQ: VIRI) experienced volatile short activity. After the activity, the stock price went down -75.50% to $0.49. The overall sentiment for VIRI has...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 21, 2022
On Wednesday, 340 stocks hit new 52-week lows.
Via
Benzinga
Dow Dips 400 Points; Ford Shares Slide
September 20, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 20, 2022
Via
Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Gainers
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 20, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 20, 2022
On Tuesday, 507 stocks hit new 52-week lows.
Via
Benzinga
Nasdaq Down 50 Points; Crude Oil Falls Sharply
September 20, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.
Via
Benzinga
Why Virios Therapeutics Shares Are Getting Hammered
September 20, 2022
Virios Therapeutics Inc (NASDAQ: VIRI) shares are trading lower by 74.50% to $0.51 Tuesday morning after the company priced a 10 million share public offering at $0.50 per share. Also, HC Wainwright &...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
September 20, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 20, 2022
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
September 20, 2022
Gainers
Via
Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
Virios Therapeutics, Inc. Announces Pricing of Public Offering
September 19, 2022
From
Virios Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.